Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Perin · SciRah

Researcher profile · Semantic Scholar

A. Perin

Share profile

A. Perin — researcher profile on SciRah

h-index: 13
Works: 62
Citations: 666

Most-cited papers

The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.
L. Trentin, C. Agostini, M. Facco, F. Piazza +7 more
1999Journal of Clinical Investigation170 citations Open access
Semantic Scholar
Telomerase activity in chronic lymphoproliferative disorders of B‐cell lineage
L. Trentin, G. Ballon, L. Ometto, A. Perin +4 more
1999British Journal of Haematology66 citations
Semantic Scholar
Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer.
M. Nicoletto, C. Falci, D. Pianalto, G. Artioli +6 more
2006Gynecologic Oncology53 citations
Semantic Scholar
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process.
C. Agostini, L. Trentin, A. Perin, M. Facco +6 more
1999American Journal of Physiology - Lung cellular and Molecular Physiology53 citations
Semantic Scholar
Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
G. Ferraccioli, R. Assaloni, A. Perin
2002The Lancet41 citations
Semantic Scholar
Prognostic Role of Circulating Tumor Cells (CTCS) in Metastatic Renal Cell Carcinoma: A Large, Multicenter Prospective Trial.
U. Basso, A. Facchinetti, E. Rossi, M. Maruzzo +19 more
2021The Oncologist35 citations Open access
Semantic Scholar
CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction.
C. Agostini, R. Zambello, M. Facco, A. Perin +6 more
1999Blood34 citations
Semantic Scholar
Switching to etanercept in patients with rheumatoid arthritis with no response to infliximab.
E. Di Poi, A. Perin, M. Morassi, M. Del Frate +2 more
2007Clinical and Experimental Rheumatology31 citations
Semantic Scholar
B7 costimulatory molecules from malignant cells in patients with B‐cell chronic lymphoproliferative disorders trigger T‐cell proliferation
L. Trentin, A. Perin, M. Siviero, F. Piazza +8 more
2000Cancer25 citations Open access
Semantic Scholar
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus
L. Quartuccio, S. Sacco, N. Franzolini, A. Perin +2 more
2006Lupus24 citations
Semantic Scholar
Drug-induced systemic lupus erythematosus and TNF-α blockers
G. Ferraccioli, R. Assaloni, A. Perin
200221 citations
Semantic Scholar
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
A. Diminutto, U. Basso, M. Maruzzo, F. Morelli +14 more
2016Clinical Genitourinary Cancer17 citations Open access
Semantic Scholar
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy.
L. Doni, A. Perin, L. Manzione, V. Gebbia +10 more
2011Critical reviews in oncology/hematology15 citations
Semantic Scholar
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.
O. Caffo, G. Lo Re, T. Sava, S. Buti +14 more
2015Future Oncology11 citations
Semantic Scholar
Surveillance of screening for hepatitis C through the laboratory network RENA-VHC, France, 2000-2001.
C. Meffre, C. Larsen, A. Perin, L. Bouraoui +1 more
2003Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin11 citations Open access
Semantic Scholar
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
A. Veccia, O. Caffo, U. de Giorgi, G. Di Lorenzo +32 more
2016Future Oncology9 citations
Semantic Scholar
Analysis of clinical features of ovarian cancer (OC) and breast cancer (BC) among BRCA-mutated (BRCA+) and sporadic (NH) double tumors.
M. Nicoletto, L. Borgato, G. Artioli, A. Perin +11 more
20126 citations
Semantic Scholar
Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: results from a phase II study.
O. Caffo, L. Fratino, R. Barbieri, A. Perin +8 more
2013Urologic oncology5 citations
Semantic Scholar
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process.
C. Agostini, L. Trentin, A. Perin, M. Facco +6 more
1999American Journal of Physiology5 citations
Semantic Scholar
Hypovitaminosis D in an hospitalized old population of Western Friuli.
A. Perin, E. Zanatta, E. Pigatto, S. Carniello +1 more
2012Reumatismo4 citations Open access
Semantic Scholar
IMPACT OF DOCETAXEL (D) – BASED CHEMOTHERAPY ON QUALITY OF LIFE (QOL) OF PATIENTS (PTS) WITH HORMONE- REFRACTORY PROSTATE CANCER (HRPC): RESULTS FROM A RANDOMISED PHASE II TRIAL WITH D ± ESTRAMUSTINE (E)
O. Caffo, T. Sava, E. Comploj, Z. Zustovich +6 more
20084 citations
Semantic Scholar
A multicentric phase II randomized trial of docetaxel (D) plus estramustine (E) versus docetaxel (D) as first line chemotherapy for patients (pts) with hormone-refractory advanced prostate cancer (HRPC).
O. Caffo, T. Sava, E. Comploj, A. Fariello +7 more
2006Journal of Clinical Oncology4 citations
Semantic Scholar
Prognostic role of circulating tumor cells-CTCs in metastatic renal cell carcinoma.
U. Basso, A. Facchinetti, E. Rossi, M. Maruzzo +16 more
20173 citations
Semantic Scholar
Surveillance des activités de dépistage et contrôle de dépistage de l’hépatite C au sein du réseau de laboratoires RENA-VHC, France, 2000-2001
C. Meffre, C. Larsen, A. Perin, L. Bouraoui +1 more
20033 citations
Semantic Scholar
[Splenectomy in the radical surgical treatment of ovarian carcinoma].
Carlo Scarabelli, Elio Campagnutta, A. Perin, Francesco Sopracordevole +3 more
1985Minerva Ginecologica3 citations
Semantic Scholar
Clinical outcomes and toxicity of estramustine phosphate (EP) addition to docetaxel (D) as first-line therapy for castration-resistant prostate cancer (CRPC): A cumulative analysis on 243 patients (pts) from two randomized phase II trials.
O. Caffo, T. Sava, F. Zustovich, M. Lodde +11 more
2013Journal of Clinical Oncology1 citations
Semantic Scholar
Impact of intermittent (I) first-line docetaxel (D)-based chemotherapy on quality of life (QL) of patients (pts) with castration-resistant prostate cancer (CRPC): Results of a phase II randomized trial.
O. Caffo, T. Sava, U. Basso, S. Buti +9 more
2013Journal of Clinical Oncology1 citations
Semantic Scholar
Clinical outcome (CO) evaluation of very old (≥ 80 years) castration resistant prostate cancer (CRPC) patients (pts) treated with docetaxel (DOC): Preliminary results of an Italian multicenter retrospective study (DELPHI study).
F. Maines, S. Burgio, G. Di Lorenzo, F. Scognamiglio +16 more
20131 citations
Semantic Scholar
Preliminary results of a factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (DOC) with or without estramustine (E) as first-line treatment for castration-resistant prostate cancer (CRPC) (HOPLITE trial).
O. Caffo, G. Lo Re, T. Sava, S. Buti +13 more
2012Journal of Clinical Oncology1 citations
Semantic Scholar
Factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (D) with or without estramustine (E) as first-line treatment for castration-resistant prostate cancer (CRPC): Preliminary results of HOPLITE trial.
O. Caffo, G. L. Re, T. Sava, S. Buti +12 more
20121 citations
Semantic Scholar
Docetaxel (D) and estramustine (E) as first-line chemotherapy for patients (pts) with hormone-refractory advanced prostate cancer (HRPC): Final results of a multicentric phase II randomized trial
O. Caffo, T. Sava, E. Comploj, M. Giampaolo +6 more
20071 citations
Semantic Scholar
Nonseminomatous germ cell testicular tumors clinical stage II: Retroperitoneal lymph node dissection, chemotherapy or both?
T. Sava, S. Pessa, L. Nicoletti, A. Perin +6 more
2004Journal of Clinical Oncology1 citations
Semantic Scholar
Drug-induced systemic lupus erythematosus and TNF-α blockers. Authors' reply
G. Ferraccioli, R. Assaloni, A. Perin, N. Shakoor +6 more
20021 citations
Semantic Scholar
A phase II study of leucovorin (LV)-modulated continuous infusion (CI) fluorouracil (DU) + CPT-11 alternating with LV-modulated CI FU + Oxaliplatin (L-OHP) in advanced colorectal cancer (CCR): high activity and low toxicity
A. Aschele, S. Lonardi, L. Sartor, A. Perin +3 more
20011 citations
Semantic Scholar
[Changes in the activity of various enzymes in experimental atherosclerosis].
C. Severi, C. Agostini, A. Perin
1957Lo sperimentale1 citations
Semantic Scholar
From clinical trials to real-world practice: six-months of mirvetuximab soravtansine experience in the veneto region, italy.
Giulia Tasca, V. Parolin, A. Perin, F. Bassan +8 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Postmenopausal Stage IV Ovarian Yolk Sac Tumor With Neuroendocrine Features: Report of a Rare Case
S. Fucina, Lucia Lerda, M. Bartoletti, A. Perin +2 more
2026Anticancer Research0 citations
Semantic Scholar
Erratum: Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284)
O. Caffo, G. L. Re, T. Sava, S. Buti +14 more
20150 citations
Semantic Scholar
D05Intraperitoneal chemotherapy in pretreated ovarian cancer patients: a retrospective case-control study
Alessandra Casarin, M. Nicoletto, S. Valpione, A. Baldoni +7 more
20150 citations Open access
Semantic Scholar
Dose calculation and tolerability of adjuvant AUC 7 carboplatin in 100 patients with stage I seminoma.
U. Basso, A. Diminutto, F. Morelli, U. de Giorgi +12 more
20140 citations
Semantic Scholar
Interaction T-Cell - Costimulatory Pathways Involved in the Antigen-Presenting Cells Immunodeficiency Virus Infection. Interleukin-15 Upmodulates CD8 T-Cell Infiltration in Extravascular Tissues of Patients With Human
U. Basso, M. Bortolin, L. Trentin, G. Semenzato +6 more
20130 citations
Semantic Scholar
P118 Preliminary results of HOPLITE trial, a factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (D) ± estramustine (E) as first line treatment for castration resistant prostate cancer (CRPC)
O. Caffo, G. L. Re, T. Sava, S. Buti +13 more
20120 citations
Semantic Scholar
Preliminary results of a factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (DOC) with or without estramustine (E) as first-line treatment for castration-resistant prostate cancer (CRPC) (HOPLITE trial).
O. Caffo, G. Lo Re, T. Sava, S. Buti +13 more
2012Journal of Clinical Oncology0 citations
Semantic Scholar
305 RESULTS OF A MULTICENTRIC PHASE II RANDOMIZED TRIAL WITH DOCETAXEL (D) ± ESTRAMUSTINE (E) AS FIRST LINE CHEMOTHERAPY FOR PATIENTS (PTS) WITH HORMONE-REFRACTORY ADVANCED PROSTATE CANCER (HRPC)
O. Caffo, E. Comploj, T. Sava, G. Mansueto +9 more
20070 citations
Semantic Scholar
Predictive value of PSA halving index (PSAHI) in patients (pts) with hormone refractory prostate cancer (HPRC): Results from a randomized phase II trial with docetaxel (D) {+/-} estramustine phopshate (E)
T. Sava, E. Comploj, G. Fariello, F. Zustovich +6 more
20070 citations
Semantic Scholar
Efficacy of pegylated liposomal doxorubicin (PLD) and oxaliplatin (OX) in pre-treated advanced epithelial ovarian cancer (EOC) and relation to p53 status.
M. Nicoletto, M. Donach, L. Borgato, F. Angelini +7 more
2006Journal of Clinical Oncology0 citations
Semantic Scholar
Study of liposomal doxorubicin (LD) and oxaloplatin (OX) in pre-treated epithelial ovarian cancer (EOC)
M. Nicoletto, C. Falci, G. Crepaldi, P. Azzoni +5 more
20050 citations
Semantic Scholar
A phase I study of weekly oxaliplatin (OXA) + continous infusion (CI) fluorouracil (FU) in patients with advanced colorectal cancer(CCR)
A. Aschele, S. Lonardi, L. Sartor, A. Perin +3 more
20010 citations
Semantic Scholar
OP0070 Non-malignant lymphoproliferation in sjoegren’s syndrome: proposed classification based on integrated clinico-phatologic and molecular studies and follow-up
S. de Vita, C. Scott, M. Fabris, R. Damato +3 more
20010 citations
Semantic Scholar
Sarcoid Granulomatous Reactions Involvement of the IP-10 Chemokine in Semenzato Chilosi
C. Agostini, M. Cassatella, R. Zambello, L. Trentin +10 more
19980 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Sava×20
Invite
T. Sava — researcher profile on SciRah
U. Basso×16
Invite
U. Basso — researcher profile on SciRah
O. Caffo×16
Invite
O. Caffo — researcher profile on SciRah
F. Zustovich×15
Invite
F. Zustovich — researcher profile on SciRah

×13

Invite

C. Sacco — researcher profile on SciRah

E. Galligioni×13

Invite

E. Galligioni — researcher profile on SciRah

Invite

A. Veccia — researcher profile on SciRah

G. Pappagallo×11

Invite

G. Pappagallo — researcher profile on SciRah

G. Facchini×10

Invite

G. Facchini — researcher profile on SciRah

Invite

C. Barile — researcher profile on SciRah

Invite

L. Trentin — researcher profile on SciRah

G. Semenzato×8

Invite

G. Semenzato — researcher profile on SciRah